Madrigal Pharmaceuticals, Inc. (MDGL)

501.68 +5.80 (+1.17%) USD  |  NASDAQ  |  Jan 16, 16:00
501.64 -0.04 (-0.01%) After-Hours: 20:00
More

Madrigal Pharmaceuticals Extraordinary Items, Income Statement (Quarterly)

Extraordinary Items, Income Statement (Quarterly) Chart

View Extraordinary Items, Income Statement (Quarterly) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Extraordinary Items, Income Statement (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years

View Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Extraordinary Items, Income Statement (Quarterly) Benchmarks

View Extraordinary Items, Income Statement (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Amgen, Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade